Tumor hypoxia and cancer progression

Cancer Letters

Volumn 237, Issue 1, 2006, Pages 10-21

  Zhou, Jie ^a   Schmid, Tobias ^a   Schnitzer, Steffen ^a   Brüne, Bernhard ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Acidosis; Apoptosis; Bcl 2; HIF 1; p53; Tumor

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; PROTEIN BCL 2; PROTEIN BNIP3; PROTEIN NOXA; PROTEIN P53;

ACIDOSIS; ANGIOGENESIS; APOPTOSIS; CANCER GROWTH; CELL DEATH; CELL ENERGY; CELL HYPOXIA; CELL PH; CELL PROLIFERATION; CELL SURVIVAL; GENE MUTATION; HUMAN; MOLECULAR MECHANICS; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; OXYGEN TENSION; OXYGENATION; PRIORITY JOURNAL; SHORT SURVEY;

EID: 33646503038     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.05.028     Document Type: Review

References (67)

1. Semenza G.L. Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda) 19 (2004) 176-182
2. Kaelin Jr. W.G. How oxygen makes its presence felt. Genes Dev. 16 (2002) 1441-1445
3. Pugh C.W., and Ratcliffe P.J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9 (2003) 677-684
4. Jaakkola P., Mole D.R., Tian Y.M., Wilson M.I., Gielbert J., Gaskell S.J., et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292 (2001) 468-472
5. Ivan M., Kondo K., Yang H., Kim W., Valiando J., Ohh M., et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292 (2001) 464-468
6. Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., et al. EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107 (2001) 43-54
7. Bruick R.K., and McKnight S.L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294 (2001) 1337-1340
8. Maxwell P.H., Wiesener M.S., Chang G.-W., Clifford S.C., Vaux E.C., Cockman M.E., et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399 (1999) 271-275
9. Salceda S., and Caro J. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. J. Biol. Chem. 272 (1997) 22642-22647
10. Huang L.E., Gu J., Schau M., and Bunn H.F. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl Acad. Sci. USA 95 (1998) 7987-7992
11. Roach P.L., Clifton I.J., Fulop V., Harlos K., Barton G.J., Hajdu J., et al. Crystal structure of isopenicillin N synthase is the first from a new structural family of enzymes. Nature 375 (1995) 700-704
12. Hirsila M., Koivunen P., Gunzler V., Kivirikko K.I., and Myllyharju J. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J. Biol. Chem. 278 (2003) 30772-30780
13. Gerald D., Berra E., Frapart Y.M., Chan D.A., Giaccia A.J., Mansuy D., et al. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118 (2004) 781-794
14. Lando D., Peet D.J., Whelan D.A., Gorman J.J., and Whitelaw M.L. Asparagine hydroxylation of the HIF transactivation domain: a hypoxic switch. Science 295 (2002) 858-861
15. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3 (2003) 721-732
16. Greijer A.E., and van der Wall E. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J. Clin. Pathol. 57 (2004) 1009-1014
17. O'Reilly M.S., Holmgren L., Chen C., and Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat. Med. 2 (1996) 689-692
18. An W.G., Kanekal M., Simon M.C., Maltepe E., Blagosklonny M.V., and Neckers L.M. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 392 (1998) 405-408
19. Wenger R.H., Camenisch G., Desbaillets I., Chilov D., and Gassmann M. Up-regulation of hypoxia-inducible factor-1alpha is not sufficient for hypoxic/anoxic p53 induction. Cancer Res. 58 (1998) 5678-5680
20. Koumenis C., Alarcon R., Hammond E., Sutphin P., Hoffman W., Murphy M., et al. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol. Cell. Biol. 21 (2001) 1297-1310
21. Achison M., and Hupp T.R. Hypoxia attenuates the p53 response to cellular damage. Oncogene 22 (2003) 3431-3440
22. Pan Y., Oprysko P.R., Asham A.M., Koch C.J., and Simon M.C. p53 cannot be induced by hypoxia alone but responds to the hypoxic microenvironment. Oncogene 23 (2004) 4975-4983
23. Hansson L.O., Friedler A., Freund S., Rudiger S., and Fersht A.R. Two sequence motifs from HIF-1alpha bind to the DNA-binding site of p53. Proc. Natl Acad. Sci. USA 99 (2002) 10305-10309
24. Chen D., Li M., Luo J., and Gu W. Direct interactions between HIF-1alpha and Mdm2 modulate p53 function. J. Biol. Chem. 278 (2003) 13595-13598
25. Ravi R., Mookerjee B., Bhujwalla Z.M., Sutter C.H., Artemov D., Zeng Q., et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev. 14 (2000) 34-44
26. Schmid T., Zhou J., Kohl R., and Brune B. p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1). Biochem. J. 380 (2004) 289-295
27. Blagosklonny M.V., An W.G., Romanova L.Y., Trepel J., Fojo T., and Neckers L. p53 inhibits hypoxia-inducible factor-stimulated transcription. J. Biol. Chem. 273 (1998) 11995-11998
28. Fei P., Wang W., Kim S.H., Wang S., Burns T.F., Sax J.K., et al. Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth. Cancer Cell 6 (2004) 597-609
29. Bruick R.K. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc. Natl Acad. Sci. USA 97 (2000) 9082-9087
30. Vande Velde C., Cizeau J., Dubik D., Alimonti J., Brown T., Israels S., et al. BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol. Cell. Biol. 20 (2000) 5454-5468
31. Kothari S., Cizeau J., McMillan-Ward E., Israels S.J., Bailes M., Ens K., et al. BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF. Oncogene 22 (2003) 4734-4744
32. Okami J., Simeone D.M., and Logsdon C.D. Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer. Cancer Res. 64 (2004) 5338-5346
33. Kubasiak L.A., Hernandez O.M., Bishopric N.H., and Webster K.A. Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proc. Natl Acad. Sci. USA 99 (2002) 12825-12830
34. Sowter H.M., Ratcliffe P.J., Watson P., Greenberg A.H., and Harris A.L. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res. 61 (2001) 6669-6673
35. Kim J.Y., Ahn H.J., Ryu J.H., Suk K., and Park J.H. BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha. J. Exp. Med. 199 (2004) 113-124
36. Papandreou I., Krishna C., Kaper F., Cai D., Giaccia A.J., and Denko N.C. Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment. Cancer Res. 65 (2005) 3171-3178
37. Dennis S.C., Gevers W., and Opie L.H. Protons in ischemia: where do they come from; where do they go to?. J. Mol. Cell. Cardiol. 23 (1991) 1077-1086
38. Hochachka P.W., and Mommsen T.P. Protons and anaerobiosis. Science 219 (1983) 1391-1397
39. Zheng M., Reynolds C., Jo S.H., Wersto R., Han Q., and Xiao R.P. Intracellular acidosis-activated p38 MAPK signaling and its essential role in cardiomyocyte hypoxic injury. FASEB J. 19 (2005) 109-111
40. Webster K.A., Discher D.J., Kaiser S., Hernandez O., Sato B., and Bishopric N.H. Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53. J. Clin. Invest. 104 (1999) 239-252
41. Maxwell P.H., Dachs G.U., Gleadle J.M., Nicholls L.G., Harris A.L., Stratford I.J., et al. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl Acad. Sci. USA 94 (1997) 8104-8109
42. Jiang B.H., Agani F., Passaniti A., and Semenza G.L. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res. 57 (1997) 5328-5335
43. Ryan H.E., Lo J., and Johnson R.S. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 17 (1998) 3005-3015
44. Carmeliet P., Dor Y., Herbert J.M., Fukumura D., Brusselmans K., Dewerchin M., et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394 (1998) 485-490
45. Zhang X., Kon T., Wang H., Li F., Huang Q., Rabbani Z.N., et al. Enhancement of hypoxia-induced tumor cell death In vitro and radiation therapy in vivo by use of small interfering RNA targeted to hypoxia-inducible factor-1alpha. Cancer Res. 64 (2004) 8139-8142
46. Yu E.Z., Li Y.Y., Liu X.H., Kagan E., and McCarron R.M. Antiapoptotic action of hypoxia-inducible factor-1 alpha in human endothelial cells. Lab. Invest. 84 (2004) 553-561
47. Zhang Q., Zhang Z.F., Rao J.Y., Sato J.D., Brown J., Messadi D.V., and Le A.D. Treatment with siRNA and antisense oligonucleotides targeted to HIF-1alpha induced apoptosis in human tongue squamous cell carcinomas. Int. J. Cancer 111 (2004) 849-857
48. Akakura N., Kobayashi M., Horiuchi I., Suzuki A., Wang J., Chen J., et al. Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res. 61 (2001) 6548-6554
49. Erler J.T., Cawthorne C.J., Williams K.J., Koritzinsky M., Wouters B.G., Wilson C., et al. Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance. Mol. Cell. Biol. 24 (2004) 2875-2889
50. Park S.Y., Billiar T.R., and Seol D.W. Hypoxia inhibition of apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Biochem. Biophys. Res. Commun. 291 (2002) 150-153
51. Dong Z., Venkatachalam M.A., Wang J., Patel Y., Saikumar P., Semenza G.L., et al. Up-regulation of apoptosis inhibitory protein IAP-2 by hypoxia. Hif-1-independent mechanisms. J. Biol. Chem. 276 (2001) 18702-18709
52. Piret J.P., Minet E., Cosse J.P., Ninane N., Debacq C., Raes M., and Michiels C. Hypoxia-inducible Factor-1-dependent Overexpression of Myeloid cell factor-1 protects hypoxic cells against tert-butyl hydroperoxide-induced apoptosis. J. Biol. Chem. 280 (2005) 9336-9344
53. Dong Z., and Wang J. Hypoxia selection of death-resistant cells. A role for Bcl-X(L). J. Biol. Chem. 279 (2004) 9215-9221
54. Baek J.H., Jang J.E., Kang C.M., Chung H.Y., Kim N.D., and Kim K.W. Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis. Oncogene 19 (2000) 4621-4631
55. Liu W., Davis D.W., Ramirez K., McConkey D.J., and Ellis L.M. Endothelial cell apoptosis is inhibited by a soluble factor secreted by human colon cancer cells. Int. J. Cancer 92 (2001) 26-30
56. Rehman J., Traktuev D., Li J., Merfeld-Clauss S., Temm-Grove C.J., Bovenkerk J.E., et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109 (2004) 1292-1298
57. Zhang S.X., Gozal D., Sachleben Jr. L.R., Rane M., Klein J.B., and Gozal E. Hypoxia induces an autocrine-paracrine survival pathway via platelet-derived growth factor (PDGF)-B/PDGF-beta receptor/phosphatidylinositol 3-kinase/Akt signaling in RN46A neuronal cells. FASEB J. 17 (2003) 1709-1711
58. Qi H., and Ohh M. The von Hippel-Lindau tumor suppressor protein sensitizes renal cell carcinoma cells to tumor necrosis factor-induced cytotoxicity by suppressing the nuclear factor-kappaB-dependent antiapoptotic pathway. Cancer Res. 63 (2003) 7076-7080
59. Walmsley S.R., Print C., Farahi N., Peyssonnaux C., Johnson R.S., Cramer T., et al. Hypoxia-induced neutrophil survival is mediated by HIF-1{alpha}-dependent NF-{kappa}B activity. J. Exp. Med. 201 (2005) 105-115
60. Hockel M., and Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J. Natl Cancer Inst. 93 (2001) 266-276
61. Wang J.H., Wu Q.D., Bouchier-Hayes D., and Redmond H.P. Hypoxia upregulates Bcl-2 expression and suppresses interferon-gamma induced antiangiogenic activity in human tumor derived endothelial cells. Cancer 94 (2002) 2745-2755
62. Piret J.P., Mottet D., Raes M., and Michiels C. CoCl2, a chemical inducer of hypoxia-inducible factor-1, and hypoxia reduce apoptotic cell death in hepatoma cell line HepG2. Ann. NY Acad. Sci. 973 (2002) 443-447
63. Unruh A., Ressel A., Mohamed H.G., Johnson R.S., Nadrowitz R., Richter E., et al. The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy. Oncogene 22 (2003) 3213-3220
64. Aebersold D.M., Burri P., Beer K.T., Laissue J., Djonov V., Greiner R.H., and Semenza G.L. Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res. 61 (2001) 2911-2916
65. Birner P., Schindl M., Obermair A., Breitenecker G., and Oberhuber G. Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin. Cancer Res. 7 (2001) 1661-1668
66. Koukourakis M.I., Giatromanolaki A., Skarlatos J., Corti L., Blandamura S., Piazza M., et al. Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res. 61 (2001) 1830-1832
67. Volm M., and Koomagi R. Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. Anticancer Res. 20 (2000) 1527-1533